Login Logout

NOW Closed – Now closed to investment.

Fund facts

Asset Class
Global Real Estate
169 358 196
PDS Date
May 20, 2014
Suggested Investment Period
At least 7 Years
Annually as at 30 June
N/A - The Fund is closed ended
Closed to new investment
Wrap Access
BT Wrap, Asgard and Colonial First State. Others please contact Spire Capital for further information.
Investment Partner

Spire’s second Fund has again partnered with US based Bridge Investment Group Partners, LLC, to provide Australian investors with the ability to access income and growth via an investment in the US Senior Housing and Medical Properties market.

Like Spire’s inaugural “ROC II” Fund, Spire USA ROC Senior Housing and Medical Properties Fund (AUD), will operate as a feeder fund to the underlying US investments sourced and managed by Spire’s US real estate partner, Bridge Investment Group Partners, LLC.

The Fund acts as an Australian feeder fund into the assets of ROC Seniors Housing and Medical Properties Fund, LP (“ROC Seniors”). ROC Seniors is a “buy, fix, sell” private equity real estate fund, investing in income producing and value-add US seniors housing and medical office properties.

The Fund owns a proportionate share of a current diversified portfolio of 50 separate real estate assets across the US, which have been acquired for approximately US$1.5 billion.

During ROC Senior’s 4 year Investment Period, the portfolio is expected to grow to US$2 billion in income generating assets.

Following the Investment Period, an exit strategy will be executed, which may include an IPO or trade sale of the portfolio.

The Fund will acquire assets that will benefit from what is being called the “Silver Tsunami’ – the US ageing population demographic, in which over 10,000 people per day are turning 65.

Each asset acquired will have a value-add strategy which will be implemented to increase the property’s cash flow and total return. In many cases this will involve increasing the number of Memory Care beds in a facility. Memory Care is a relatively new specialist sector and asset class within the US senior housing market, which provides specialist accommodation and care programs for residents afflicted with dementia; the leading cause of which is Alzheimer’s disease.

Currently in the US, there are over 5 million people living with Alzheimer’s and someone develops Alzheimer’s every 68 seconds. Yet there are only 35,000 Memory Care beds available. Accordingly, most Memory Care facilities are 100% occupied – with waiting lists.

Following the amalgamation of the portfolio during the Fund’s Investment Period, Bridge will asses the method and timing of the most profitable exit strategy for the portfolio. It is expected that this exit strategy will seek to exploit the pricing differences between the private markets and the public markets, via a portfolio or portfolio sales to publicly traded Real Estate Investment Trusts (REITs), or via an Initial Public Offering (IPO) of the portfolio as a new REIT. Alternatively individual assets may be sold when value has been maximised.

The Bridge Investment and Asset Management team behind the underlying ROC Seniors program, concluded a similar strategy in 2006 via the sale of a US$5 Billion portfolio of US Senior Housing properties to a publicly traded REIT, generating a portfolio Internal Rate of Return (IRR) of 33% (p.a.).

The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned 20 May 2014) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at http://www.zenithpartners. com.au/ RegulatoryGuidelines.

Ordinary Units

Performance as at 30 April 2024 Net Returns*
1 month-3.00%
3 months-5.45%
6 months-9.57%
1 year-22.17%
Performance Since inception **-2.37%

*Past performance is not an indicator of future performance. ** Performance Since Inception – Inception date (08 December 2015) occurred from the commencement of NAV based unit pricing, following the completion of capital raising in December 2015. Please note, however, that each investor’s performance numbers are calculated on an individual basis from their time of application and may differ from the above. “Performance since inception” is measured as the Internal Rate of Return since inception. The IRR is the annualised rate of return that equates the amount and timing of irregular cashflows since inception with the period end value. For the purposes of the monthly report, the IRR replaces the time weighted return since inception effective 30 June 2023.

Date Unit Price Net Monthly Return
30 April 2024$0.8611-3.00%

Fund Documents

Off Market Transfer Form
Change of Contact Details Form
Change of Advisor Form
Change for Bank Details Form
TFN/ABN Notification Form


Zenith Research Report
PeriodDistribution Amount (cents per unit)EX PriceDistribution Components
30 June 2023 Nil CPU cash, Nil CPU FITOs $1.0308
30 June 2022 Nil CPU cash; Nil CPU FITOs $1.3341
30 June 2021 Nil CPU cash; Nil CPU FITOs $1.2949
30 June 2020 Nil CPU cash; 0.2682 CPU FITOs $1.4126
30 June 2019 1.2781 CPU cash; 0.2757 CPU FITOs $1.3697
30 June 2018 7.9420 CPU cash; 0.3675 CPU FITOs $1.2302
30 June 2017 1.7531 CPU cash; 0.3165 CPU FITOs $1.2012
30 June 2016 0.5171 CPU cash; 0.1151 CPU FITOs $1.1678